CHGX Share Price Performance
CA$0.005
-0.01 (-50.00%)
Price CA$0.005
Share PriceCA$0.005
ChitogenX Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CHGX Community Narratives
There are no narratives available yet.
Recent CHGX News & Updates
ChitogenX Inc. Key Details
Last Reported Earnings
Oct 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.019
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -57.5%
ChitogenX Inc. Competitors
Snowflake Analysis
About CHGX
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.3%
- 3 Months: 11.0%
- 1 Year: 22.5%
- Year to Date: 20.2%
The market is up 1.3% over the last week, with the Materials sector leading the way, up 3.0%. The market is up 22% over the last 12 months. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›